OncoSeer Diagnostics, Inc. is a biotech startup using novel multiomic biomarkers and AI modeling across our highly annotated cohort to screen, monitor and diagnose immune related adverse events (irAE's) prior to immune checkpoint inhibitor (ICI) treatments. Our aim is to provide oncologists and pharma an informed way to increase access to ICI's in patients having an early-stage cancer, a prior autoimmune disease, or needing combo ICI treatments where access may be resticted.
OncoSeer Diagnostics, Inc.的外部链接
US，Texas，Dallas
An excellent article by Dr David Gerber UT Southwestern Medical Center about improving access to cancer clinical trials across Texas for underserved communities.
UT Southwestern has received four new grants to improve access to cancer clinical trials across Texas, especially for underserved communities. These grants support innovative research to find effective treatments and improve patient outcomes. Learn more: https://bit.ly/4dcCKri